Stephen Bright is a Psychologist, Ethnopharmacologist and Founding Member and Vice-President of PRISM (Psychedelic Research in Science & Medicine), an independent non-profit research organization on Psychedelics. We dived into the current state of psychedelic research in Australia and talked about the first MDMA assisted clinical trials about to start in Perth to treat PTSD & Depression.
Links:
https://www.prism.org.au/tag/stephen-bright/
https://www.ecu.edu.au/schools/medical-and-health-sciences/our-staff/profiles/senior-lecturers/dr-stephen-bright
https://twitter.com/stephenjbright?lang=en
Episode Notes:
4:22 Current Updates on Psychedelics Research in Australia
6:11 The First successful trial of Psilocybin in Australia
15:08 Interesting facts on young people and drugs
31:12 Mystical Experiences from Psychoactive drugs
39:10 Psychedelic drugs are neutral
45:30 Eye-opening experiences in Psychedelic studies
50:10 Why were Psilocybin mushrooms banned?
52:33 Estimated costs to produce and access Psychedelics
